Pages that link to "Q34522222"

The following pages link to Cancer-associated autoantibodies to MUC1 and MUC4--a blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screening (Q34522222):

Displaying 20 items.

• Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer. (Q33608271) (← links)
• Serum N-glycome characterization and anti-carbohydrate antibody profiling in oral squamous cell carcinoma patients (Q33778489) (← links)
• Anti-p21 autoantibodies detected in colorectal cancer patients: A proof of concept study (Q35201847) (← links)
• The antigenic repertoire of premalignant and high-risk lesions (Q35251460) (← links)
• Blood Plasma-Derived Anti-Glycan Antibodies to Sialylated and Sulfated Glycans Identify Ovarian Cancer Patients (Q36169039) (← links)
• Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting (Q37086048) (← links)
• Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma (Q37621102) (← links)
• High-Throughput Analysis of Plasma Hybrid Markers for Early Detection of Cancers (Q37636426) (← links)
• Glycosylation in cancer: mechanisms and clinical implications (Q38569702) (← links)
• Viral O-GalNAc peptide epitopes: a novel potential target in viral envelope glycoproteins. (Q38622432) (← links)
• MUC4 mucin- a therapeutic target for pancreatic ductal adenocarcinoma. (Q38688917) (← links)
• Humoral response against sialyl-Le(a) glycosylated protein species in esophageal cancer: Insights for immunoproteomic studies (Q38968089) (← links)
• A panel of autoantibodies against multiple tumor-associated antigens in the immunodiagnosis of esophageal squamous cell cancer (Q40610754) (← links)
• De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium. (Q47301558) (← links)
• Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer. (Q47606195) (← links)
• Circulating levels of autoantibodies against L1-cell adhesion molecule as a potential diagnostic biomarker in esophageal squamous cell carcinoma (Q50903019) (← links)
• Development of a novel multiplex beads-based assay for autoantibody detection for colorectal cancer diagnosis. (Q51493919) (← links)
• Anti-CA15.3 and Anti-CA125 Antibodies and Ovarian Cancer Risk: Results from the EPIC Cohort (Q60463376) (← links)
• Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma (Q90318254) (← links)
• Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma (Q92125828) (← links)